Passage of intravenous immunoglobulin and interaction with the CNS.
Open Access
- 1 November 1994
- journal article
- review article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 57 (Suppl) , 21-25
- https://doi.org/10.1136/jnnp.57.suppl.21
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Intravenous high-dose gammaglobulins for intractable childhood epilepsyActa Neurologica Scandinavica, 2009
- Murine tumor necrosis factor alpha is transported from blood to brain in the mouseJournal of Neuroimmunology, 1993
- Improved vision after intravenous immunoglobulin in stable demyelinating optic neuritisAnnals of Neurology, 1992
- Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new viewImmunology Today, 1992
- Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseasesClinical and Experimental Immunology, 1991
- Treatment of myasthenia gravis with high-dose intravenous immunoglobulinActa Neurologica Scandinavica, 1991
- Blood brain barrier permeability in multiple sclerosis using labelled DTPA with PET, CT and MRI.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- MS: a CNS and systematic autoimmune diseaseImmunology Today, 1989
- Successful Reversal of ECHOvirus Encephalitis in X-Linked Hypogammaglobulinemia by Intraventricular Administration of ImmunoglobulinNew England Journal of Medicine, 1985
- S‐Sulfonation: a Reversible Chemical Modification of Human Immunoglobulins Permitting Intravenous ApplicationVox Sanguinis, 1983